Owler - Instant Insight Intellia Therapeutics just raised $400M. Intellia Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases.
| | raised $400M
in a Post-IPO Debt round |
|
|
| | |
|
|
- - - - - - - - - - - - - - - - - - - - -
